Weimei Health Completes Series A Billion-Level RMB Financing to Accelerate Deployment of Medical Large Models in County and Primary Healthcare
VCBeat has learned that Weimei Health, a company focused on the innovative application of artificial intelligence in healthcare, has recently completed an A-round financing worth hundreds of millions. This round was led by Hongding Capital, with participation from Weimei Health’s angel investors.The financing will be allocated to the research and development, as well as the iterative evolution, of Weimei Health’s “Singularity Medical Inquiry” large medical language model. It will also strengthen algorithmic research in specialized medical fields, build and upgrade a nationwide service network, and expand Weimei Health’s market advantage in the AI healthcare sector for county-level and primary care institutions.
Dr. Wang Jun, co-founder of Weimei Health, pointed out, “We will launch the Singularity MedQuery ‘AI-Enabled Quality Improvement and Efficiency Enhancement Project for Primary Healthcare’ through the ‘1+1+N’ solution (one Singularity MedQuery medical large language model, one DeepSeek large language model, and N diverse medical scenarios). Together, we will build a new model of medical service characterized by ‘AI-Physician Interactive Empowerment and Incremental Evolution,’ effectively addressing critical pain points such as the shortage of high-caliber physicians in county-level and primary care settings, limited scope of medical services, and low service efficiency.”
Weimei Health, established in 2021 as a provider of smart hospital solutions, currently focuses on two core business areas. The first is foundational smart healthcare services, offering basic information technology platforms for smart hospitals to medical institutions. The second is innovative healthcare services. In the era of large AI models, Weimei Health delivers AI-integrated innovative products to medical institutions, including AI-powered preliminary disease consultation, AI triage, AI-based medical record quality control systems, AI-assisted diagnostic platforms for physicians, and AI-driven hospital performance evaluation platforms. These medical AI solutions help healthcare institutions enhance the quality of their medical services.
Currently, there are nearly 3,000 medical institutions collaborating with Weimei Health.Among them, more than 2,000 are county-level or primary healthcare institutions. Dr. Wang Jun stated that the decision to focus on the primary care sector and help primary medical service institutions improve quality and efficiency is driven by two factors. On one hand, the demand for primary medical services has not been effectively met. Currently, smart hospital initiatives are largely concentrated in first-tier cities, while exploration of the county-level medical market remains insufficient. Data shows that in 2020, the permanent resident population across 1,874 counted counties totaled 748 million, undoubtedly representing a market with substantial demand for medical services. On the other hand, national policies encourage and support the development of primary healthcare. In recent years, the state has prioritized improving medical and health service levels at the grassroots level, deepened public hospital reforms with a focus on public welfare, improved the tiered diagnosis and treatment system to promote the balanced distribution and expansion of high-quality medical resources to lower tiers, and continuously advanced the construction of National Medical Centers and National Regional Medical Centers. Under the advocacy of “ensuring serious illnesses are treated within the province, common diseases are resolved in cities and counties, and everyday ailments are managed at the primary care level,” the rapid development of informatization in primary healthcare has been further accelerated. Moreover, AI has further driven improvements in diagnostic and service capabilities within primary healthcare.
Weimei Health, which has been “dedicated to the innovative application of AI in the medical field” since its inception, aims to better leverage its digital capabilities to further benefit the vast number of patients at the grassroots level.
In 2023, Weimei Health launched the “Singularity Medical Inquiry” large medical model platform. Building on this foundation, it introduced a range of AI-driven innovative products to enhance the quality and efficiency of primary healthcare services.Following the release of the DeepSeek large language model in 2025, which sparked a wave of applications across various sectors, Weimei Health swiftly followed suit by achieving technical integration and co-evolution between the DeepSeek model and its proprietary Qidian Yiwen large language model. This synergy enables the delivery of more professional, precise, and efficient AI solutions tailored to the healthcare vertical. Furthermore, addressing the need for localized medical data management, Weimei Health has provided all-in-one appliances powered by computing infrastructure and large language models, facilitating the on-premises deployment of AI solutions for its clients.
“The rapid development of large language models (LLMs), particularly the open-sourcing of DeepSeek at the beginning of this year, has served as a significant catalyst for the entire healthcare sector, with major hospitals having successively completed their deployments of DeepSeek. Hospitals are actively embracing AI, and various specialized medical models are poised for rapid growth,” stated Dr. Wang Jun. “In this wave of AI advancement, LLMs that genuinely address accuracy, efficiency, and decision support needs for hospitals, physicians, nurses, and administrators, as well as those that enhance healthcare accessibility for patients and even the general public while supporting health management, will experience accelerated development.”
Furthermore, Weimei Health will increase its R&D investment, leveraging its senior team composed of top-tier talent from leading Chinese universities such as Tsinghua University and Beijing Institute of Technology, along with decades of accumulated experience in the medical informatics industry. By fully grasping the most authentic needs of grassroots healthcare at the county level, the company aims to deliver superior AI-driven innovative product solutions to county-level grassroots medical institutions, thereby further benefiting doctors and patients across a wide range of hospitals.
In the past, Weimei Health has also demonstrated its capability in innovative AI applications. Between 2023 and 2024, Weimei Health received numerous awards, including Outstanding IT Supplier for Healthcare and Industry (2023), Best Healthcare Platform (2023), Innovative Case of the National “AI+” Initiative (2024), and Recommended Application Cases for AI Industry Innovation Scenarios (issued by the Ministry of Industry and Information Technology, 2024). It is reported that Weimei Health has filed for and obtained a total of 67 AI-related patents to date.
andAs early as 2022, Weimei Health secured tens of millions of RMB in angel financing.The participation of both new and existing investors in this Series A financing round underscores their continued confidence in the growth prospects of Weimei Health.
For leading this round of financing,Red Ding Capital stated“‘Leveraging large AI models to enhance the quality and efficiency of primary healthcare’ is a correct and highly meaningful path, one that Weimei Health has been diligently pursuing. The core value of Weimei Health lies in empowering primary care with its self-developed ‘Singularity Medical Inquiry’ large model, addressing the urgent need to improve diagnostic and service capabilities at the grassroots level, while establishing business barriers through iterative updates. We believe it is well worth long-term investment.”
WeiMei Healthstated: “We extend our gratitude to both new and existing shareholders for their recognition and support of Weimei Health. Following this round of financing, we will accelerate technological iteration and updates, focus on AI-driven medical innovation, strengthen our technical barriers, expand our nationwide service network, and launch the ‘Singularity Medical Inquiry’ project—an AI-powered initiative to enhance the quality and efficiency of primary healthcare. This will further solidify our market advantage in the AI healthcare sector at the county and grassroots levels, laying a robust technological foundation for the digital transformation of the healthcare industry.”